Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection - Wikidata - wikimedia - TriplyDB

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

http://www.wikidata.org/entity/Q27471998

about

Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.Combined Hepatitis C Virus (HCV) Antigen-Antibody Detection Assay Does Not Improve Diagnosis for Seronegative Individuals with Occult HCV Infection Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification Hepatitis C virus: Virology, diagnosis and treatment APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.Evaluation of an antigen-antibody "combination" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections.Hepatitis C virus core antigen test in monitoring of dialysis patients.Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation SASLT practice guidelines: management of hepatitis C virus infection.Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay.Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India.Current testing strategies for hepatitis C virus infection in blood donors and the way forward Utility of enzyme-linked immunosorbent assays to test core antigen in the diagnosis and antiviral therapy management of hepatitis C virus infections.Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.Quarantine Plasma: Quo vadis?Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients.HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina.Multinational assessment of blood-borne virus testing and transfusion safety on the African continent.Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response.Evaluation of the use of a combined HCV antigen/antibody assay in routine laboratory practice.Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.Comparison of monolisa HCV Ag/Ab ULTRA with two anti-HCV assays for the detection of HCV infection in hospital setting.Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.

P2860

Q27473162-DE1FEA12-B22A-40C7-86A3-02F710730238 Q27477774-CC4FB967-F274-4885-96D7-623FDD3B3367 Q27491329-08CDB4C2-24CE-4D25-9AB5-C870ECB9824B Q28082000-72F1CB35-570C-4584-B43F-D721FFCDDC6E Q30250088-AC1C8977-3B29-4D40-8A78-10CD972AEAAE Q30426257-6D0583D9-CD58-4645-8C52-B55D56316A28 Q33450364-A07F88B6-EF17-4CB1-A981-20985536599A Q33938574-49E1089A-77C0-4E66-A2E5-A52C8AA70BD5 Q34588996-19BC1C97-F345-4B3B-BC9B-47B724052171 Q36469016-26408E88-16E5-4E2D-8477-1926B3A02D65 Q36554189-3D5DC6BA-0C10-42EE-82E6-AAE881B406B5 Q36909187-4BC282E0-0D12-4CE7-9ACD-B627A664403B Q37019765-181752F1-B9DE-439C-AFC7-273660F4B035 Q37296858-39DAEB25-A493-4252-ACDD-F41E8D84582C Q37649327-961B1D86-F4EE-483D-8F5A-09BAB12841E7 Q37682493-2887AD6B-4C8D-4904-8ADE-3A2B8D674317 Q37961619-44579585-70C2-4DB7-8593-328A30CC8389 Q38194183-3255E5E6-782F-468D-9FEC-AFBD9465E1B9 Q38198619-87698D0E-78CA-40F5-8BAA-E401E1BB0310 Q40412090-F9A44ABC-DCC5-4A88-9048-E9B27AB71DDE Q40580971-3DBA116A-4A13-4D71-9170-B859FB465A4E Q41015616-A18879D0-D5F8-4BB1-A71A-8303D10C75C6 Q41269653-AE610C20-266D-485F-BE6C-0D593E5CF7F7 Q42235935-31961426-01A3-45ED-A4BE-62D6101B4F7E Q42262651-55451701-8BE8-49B1-8058-5AAD24D00212 Q42982287-DFFE693B-8EB6-429C-A65C-91B5253871FA Q42987172-1AE75C71-A958-4605-8E0E-C531D9AC7D9A Q43000685-E55BE89C-3707-4AB9-B5BE-09EC1A9BDC5E Q43036225-A8FEE5FE-8C7F-43BA-BB66-1EB1983A6E50 Q43042302-658BBDC5-854B-446E-A628-35355F89A509 Q45374189-65CD8843-3D0E-47F9-ADA9-7C7B6E907353

P2860

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

http://www.wikidata.org/entity/Q27471998

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@ast

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@en

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@nl

type

label

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@ast

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@en

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@nl

prefLabel

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@ast

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@en

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@nl

P1433

Q27471998-6E7F758F-437F-4B38-8A62-9DFA7EDB234C

P1476

Q27471998-B7965D21-7740-4E52-A35A-B7F32F6B70CA

P2093

Q27471998-183496AA-9BC8-4469-87E5-F5CEBE104F47

Q27471998-406FF68E-027E-45F5-A4D7-F8E920A35ED2

Q27471998-43C63F24-EDFD-4E8C-BDE7-D6A48CE69B60

Q27471998-7C3D2C86-DE30-4D85-B684-C57B28BF3163

Q27471998-7D4B0F04-3F27-48CB-B4EF-30258E22E7F8

Q27471998-A881AB6A-0304-440E-A955-BB9FB6584AB5

Q27471998-AC17057B-8204-486F-B405-2B5D1F778B5E

P2860

Q27471998-154C3DA7-D6E0-4BC2-AD2C-A94E79325D60

Q27471998-17786F18-1872-4E4A-A536-25F2469A5EB2

Q27471998-22B04858-CD78-4EEF-95A1-CA5051BBACA1

Q27471998-239FCDD3-04D8-479B-94EA-794DDAC809B6

Q27471998-27420757-D48C-4CCB-AB52-08DC03C2388B

Q27471998-2E1EA7DE-3CBE-413E-9E33-2B3AF1966BEF

Q27471998-3502EEB6-47CC-4C3D-AC6A-9E92653AFDAD

Q27471998-39FE2923-C35F-4F8E-B452-8075C422087E

Q27471998-3C694996-3FEA-44B9-ACC6-A5254D1D93D9

Q27471998-3CF11E76-008C-45EA-8EF9-58670565E557

P304

Q27471998-7A2B162A-11FE-46AF-BD21-F64DA2D0087B

P31

Q27471998-0E7AB251-7AB2-4EB2-929C-AC243F532B67

P3181

Q27471998-43358162-BBFB-436D-8DF0-6863980E6907

P356

Q27471998-17613487-E929-4699-AA37-74F6C3CEE54E

P407

Q27471998-8F33C654-5679-4499-B310-856BCF84D560

P433

Q27471998-09C7838A-B128-4567-9CD7-FE2ADBD70380

P478

Q27471998-6C72399F-A0B4-420A-BB49-D864DF4B517F

P50

Q27471998-2015D653-2257-4E7F-AA44-260F5105CAA5

Q27471998-2DDB61E3-FE59-4081-A171-D6D130B30C6C

Q27471998-CF12BF63-1BB9-45BD-9932-2AC204EFD743

P577

Q27471998-C7C69A86-1205-4D9E-A071-4EAC4CFAB607

P698

Q27471998-955AF4B7-23FB-4C0B-9129-24C2DC12ADAD

P921

Q27471998-5C71D044-F74D-463A-9DCC-4E16AC7B048C

Q27471998-89530855-5B36-4C7C-9045-31489A60B602

P932

Q27471998-CA4C40E4-0055-4BBC-8CD0-50EE81AD0640

P3181

P356

JCM.43.8.3877-3883.2005

P1433

Journal of Clinical Microbiology

P1476

Simultaneous Detection of Hepa ...... rly Detection of HCV Infection

@en

P2093

Annabelle Servant-Delmas

http://www.w3.org/2001/XMLSchema#string

Annie Girault

http://www.w3.org/2001/XMLSchema#string

Michèle Maniez-Montreuil

http://www.w3.org/2001/XMLSchema#string

Nadine Le Marrec

http://www.w3.org/2001/XMLSchema#string

Nicole Simon

http://www.w3.org/2001/XMLSchema#string

Pascal Morel

http://www.w3.org/2001/XMLSchema#string

Thierry Levayer

http://www.w3.org/2001/XMLSchema#string

P2860

Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay.

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Use and interpretation of virological tests for hepatitis C.

Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.

Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

HCV core antigen as an alternative to NAT to detect HCV viremia.

Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin.

P304

3877-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3770976

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.43.8.3877-3883.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Françoise Bouchardeau

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16081925

http://www.w3.org/2001/XMLSchema#string

P921

P932

1234013

http://www.w3.org/2001/XMLSchema#string